Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 323

1.

An Innovative Public-Private Mix Model for Improving Tuberculosis Care in Vietnam: How Well are We Doing?

Thu TD, Kumar AMV, Ramaswamy G, Htun T, Van HL, Quang LVN, Thu TDT, Codlin A, Forse R, Crewsell J, Thanh HN, Viet HN, Van HB, Binh HN, Viet NN.

Trop Med Infect Dis. 2020 Feb 14;5(1). pii: E26. doi: 10.3390/tropicalmed5010026.

2.

HIV-1 Infection, Injecting Drug Use, and Neuroendocrine Response to Psychological Stress.

Ownby RL, Waldrop-Valverde D, Kumar AM, Jones D, Fernandez B, Kumar M.

J HIV AIDS. 2019 Sep;5(2). doi: 10.16966/2380-5536.167. Epub 2019 Sep 30.

3.

To start or to complete? - Challenges in implementing tuberculosis preventive therapy among people living with HIV: a mixed-methods study from Karnataka, India.

Reddy MM, Thekkur P, Ramya N, Kamath PBT, Shastri SG, Kumar RBN, Chinnakali P, Nirgude AS, Rangaraju C, Somashekar N, Kumar AMV.

Glob Health Action. 2020;13(1):1704540. doi: 10.1080/16549716.2019.1704540.

4.

HIV Care Cascade among Prisoners of the Mandalay Central Prison in Myanmar: 2011-2018.

Nom NAM, Kyaw KWY, Kumar AMV, Hone S, Thida T, Nwe TW, Soan P, Htun T, Oo HN.

Trop Med Infect Dis. 2020 Jan 1;5(1). pii: E4. doi: 10.3390/tropicalmed5010004.

5.

Cash transfer scheme for people with tuberculosis treated by the National TB Programme in Western India: a mixed methods study.

Patel BH, Jeyashree K, Chinnakali P, Vijayageetha M, Mehta KG, Modi B, Chavda PD, Dave PV, Zala CC, Shewade HD, Solanki DM, Kumar AMV.

BMJ Open. 2019 Dec 29;9(12):e033158. doi: 10.1136/bmjopen-2019-033158.

6.

Contact Investigation of Multidrug-Resistant Tuberculosis Patients: A Mixed-Methods Study from Myanmar.

Phyo AM, Kumar AMV, Soe KT, Kyaw KWY, Thu AS, Wai PP, Aye S, Saw S, Win Maung HM, Aung ST.

Trop Med Infect Dis. 2019 Dec 26;5(1). pii: E3. doi: 10.3390/tropicalmed5010003.

7.

Outcomes of Community-Based Systematic Screening of Household Contacts of Patients with Multidrug-Resistant Tuberculosis in Myanmar.

Kyaw NTT, Sithu A, Satyanarayana S, Kumar AMV, Thein S, Thi AM, Wai PP, Lin YN, Kyaw KWY, Tun MMT, Oo MM, Aung ST, Harries AD.

Trop Med Infect Dis. 2019 Dec 25;5(1). pii: E2. doi: 10.3390/tropicalmed5010002.

8.

Impact of Advocacy, Communication, Social Mobilization and Active Case Finding on TB Notification in Jharkhand, India.

Shewade HD, Gupta V, Ghule VH, Nayak S, Satyanarayana S, Dayal R, Mohanty S, Singh S, Biswas M, Reddy KK, Mallick G, Bera OP, Pandey P, Pandurangan S, Rao R, Prasad BM, Kumar AMV, Chadha SS.

J Epidemiol Glob Health. 2019 Dec;9(4):233-242. doi: 10.2991/jegh.k.190812.002.

PMID:
31854164
9.

Effects of a Peer-Led Intervention on HIV Care Continuum Outcomes Among Contacts of Children, Adolescents, and Young Adults Living With HIV in Zimbabwe.

Tapera T, Willis N, Madzeke K, Napei T, Mawodzeke M, Chamoko S, Mutsinze A, Zvirawa T, Dupwa B, Mangombe A, Chimwaza A, Makoni TM, Mandewo W, Senkoro M, Owiti P, Tripathy JP, Kumar AMV.

Glob Health Sci Pract. 2019 Dec 23;7(4):575-584. doi: 10.9745/GHSP-D-19-00210. Print 2019 Dec 23.

10.

Initiation of antiretroviral therapy or antiretroviral prophylaxis in pregnant women living with HIV registered in five townships of Mandalay, Myanmar: A cross sectional study.

Kyaw KWY, Mon AA, Phyo KH, Kyaw NTT, Kumar AMV, Lwin TT, Aung ZZ, Aung TK, Oo MM, Htun T, Ya SST, Satyanarayana S, Oo HN.

BMC Pregnancy Childbirth. 2019 Dec 5;19(1):475. doi: 10.1186/s12884-019-2627-6.

11.

Targeted active screening for tuberculosis in Zimbabwe: are field digital chest X-ray ratings reliable?

Timire C, Sandy C, Ngwenya M, Woznitza N, Kumar AMV, Takarinda KC, Sengai T, Harries AD.

Public Health Action. 2019 Sep 21;9(3):96-101. doi: 10.5588/pha.19.0003.

12.

The Reply.

Kumar AM, Bae GH, Besen J, Kwong BY, Rieger KE.

Am J Med. 2019 Nov;132(11):e812. doi: 10.1016/j.amjmed.2019.07.027. No abstract available.

PMID:
31779785
13.

Treatment for latent tuberculosis infection in low- and middle-income countries: progress and challenges with implementation and scale-up.

Harries AD, Kumar AMV, Satyanarayana S, Takarinda KC, Timire C, Dlodlo RA.

Expert Rev Respir Med. 2020 Feb;14(2):195-208. doi: 10.1080/17476348.2020.1694907. Epub 2019 Nov 25.

PMID:
31760848
14.

Tribological and Electrochemical Characterization of UHMWPE Hybrid Nanocomposite Coating for Biomedical Applications.

Ahmed Baduruthamal Z, Mohammed AS, Kumar AM, Hussein MA, Al-Aqeeli N.

Materials (Basel). 2019 Nov 7;12(22). pii: E3665. doi: 10.3390/ma12223665.

15.

Water-Erodible Xanthan-Acrylate-Polyurethane Antifouling Coating.

Rahman MM, Zahir MH, Mazumder MAJ, Kumar AM.

Polymers (Basel). 2019 Oct 16;11(10). pii: E1700. doi: 10.3390/polym11101700.

16.

HIV care among patients with presumptive tuberculosis in Masvingo district of Zimbabwe, 2017: how well are we doing?

Ndudzo C, Tripathy JP, Tauro F, Sibanda C, Chiramba M, Shamu A, Masinire K, Muchengwa T, Kumar AM.

Pan Afr Med J. 2019 Jul 3;33:158. doi: 10.11604/pamj.2019.33.158.15847. eCollection 2019.

17.

Active versus passive case finding for tuberculosis in marginalised and vulnerable populations in India: comparison of treatment outcomes.

Shewade HD, Gupta V, Satyanarayana S, Kumar S, Pandey P, Bajpai UN, Tripathy JP, Kathirvel S, Pandurangan S, Mohanty S, Ghule VH, Sagili KD, Prasad BM, Singh P, Singh K, Jayaraman G, Rajeswaran P, Biswas M, Mallick G, Naqvi AJ, Bharadwaj AK, Sathiyanarayanan K, Pathak A, Mohan N, Rao R, Kumar AMV, Chadha SS.

Glob Health Action. 2019;12(1):1656451. doi: 10.1080/16549716.2019.1656451.

18.

Tackling diabetes mellitus and tuberculosis: a new Union guide on the management of diabetes-tuberculosis.

Lin Y, Harries AD, Kumar AMV, Critchley JA, van Crevel R, Owiti P, Dlodlo RA, Kapur A.

Int J Tuberc Lung Dis. 2019 Jul 1;23(7):771-772. doi: 10.5588/ijtld.19.0119. No abstract available.

PMID:
31439106
19.

Purification, characterization and utilization of polysaccharide of Araucaria heterophylla gum for the synthesis of curcumin loaded nanocarrier.

Samrot AV, Angalene JLA, Roshini SM, Stefi SM, Preethi R, Raji P, Kumar AM, Paulraj P, Kumar SS.

Int J Biol Macromol. 2019 Nov 1;140:393-400. doi: 10.1016/j.ijbiomac.2019.08.121. Epub 2019 Aug 16.

PMID:
31425761
20.

Alcohol, harmful use and dependence: Assessment using the WHO Alcohol Use Disorder Identification Test tool in a South Indian fishermen community.

Kumar AM, Ramaswamy G, Majella MG, Bharadwaj B, Chinnakali P, Roy G.

Ind Psychiatry J. 2018 Jul-Dec;27(2):259-263. doi: 10.4103/ipj.ipj_82_15.

21.

'I am on treatment since 5 months but I have not received any money': coverage, delays and implementation challenges of 'Direct Benefit Transfer' for tuberculosis patients - a mixed-methods study from South India.

Nirgude AS, Kumar AMV, Collins T, Naik PR, Parmar M, Tao L, Akshaya KM, Raghuveer P, Yatnatti SK, Nagendra N, Nagaraja SB, Habeena S, Mn B, Rao R, Shastri S.

Glob Health Action. 2019;12(1):1633725. doi: 10.1080/16549716.2019.1633725.

22.

Are we missing 'previously treated' smear-positive pulmonary tuberculosis under programme settings in India? A cross-sectional study.

Shewade HD, Gupta V, Satyanarayana S, Kharate A, Murali L, Deshpande M, Kumar N, Pandey P, Bajpai UN, Tripathy JP, Kathirvel S, Pandurangan S, Mohanty S, Ghule VH, Sagili KD, Prasad BM, Nath S, Singh P, Singh K, Jayaraman G, Rajeswaran P, Srivastava BK, Biswas M, Mallick G, Bera OP, Jaisingh AJJ, Naqvi AJ, Verma P, Ansari MS, Mishra PC, Sumesh G, Barik S, Mathew V, Lohar MRS, Gaurkhede CS, Parate G, Bale SY, Koli I, Bharadwaj AK, Venkatraman G, Sathiyanarayanan K, Lal J, Sharma AK, Kumar AM, Chadha SS.

Version 2. F1000Res. 2019 Mar 26 [revised 2019 Jan 1];8:338. doi: 10.12688/f1000research.18353.2. eCollection 2019.

23.

Retesting for verification of HIV diagnosis before antiretroviral therapy initiation in Harare, Zimbabwe: Is there a gap between policy and practice?

Dupwa B, Kumar AMV, Tripathy JP, Mugurungi O, Takarinda KC, Dzangare J, Bara H, Mukeredzi I.

Trans R Soc Trop Med Hyg. 2019 Oct 11;113(10):610-616. doi: 10.1093/trstmh/trz047.

PMID:
31225614
24.

Building sustainable operational research capacity in Pakistan: starting with tuberculosis and expanding to other public health problems.

Fatima R, Yaqoob A, Qadeer E, Hinderaker SG, Heldal E, Zachariah R, Harries AD, Kumar AMV.

Glob Health Action. 2019;12(1):1555215. doi: 10.1080/16549716.2018.1555215.

25.

Eosinophilic Granulomatosis With Polyangiitis: Histopathological Confirmation Despite Negative Serology.

Kumar AM, Bae GH, Besen J, Kwong BY, Rieger KE.

Am J Med. 2019 Oct;132(10):e741-e743. doi: 10.1016/j.amjmed.2019.04.032. Epub 2019 May 14. No abstract available.

PMID:
31100285
26.

Pre-treatment loss to follow-up and treatment delay among bacteriologically-confirmed tuberculosis patients diagnosed in Mandalay Region, Myanmar.

Htwe KK, Kyaw NTT, Kumar AMV, Kyaw KWY, Oo MM, Thwin T, Saw S, Aung ST.

Trop Med Health. 2019 May 2;47:30. doi: 10.1186/s41182-019-0154-9. eCollection 2019.

27.

Corrigendum: Hyperglycemia and Risk of All-cause Mortality Among People Living With HIV With and Without Tuberculosis Disease in Myanmar (2011-2017).

Kyaw NTT, Satyanarayana S, Oo HN, Kumar AMV, Harries AD, Aung ST, Kyaw KWY, Phyo KH, Aung TK, Magee MJ.

Open Forum Infect Dis. 2019 Apr 2;6(4):ofz143. doi: 10.1093/ofid/ofz143. eCollection 2019 Apr.

28.

Tuberculosis-diabetes screening: how well are we doing? A mixed-methods study from North India.

Majumdar A, Wilkinson E, Rinu PK, Maung TM, Bachani D, Punia JS, Jain S, Yadav T, Jarhyan P, Mohan S, Kumar AMV.

Public Health Action. 2019 Mar 21;9(1):3-10. doi: 10.5588/pha.18.0048.

29.

How Can Operational Research Help to Eliminate Tuberculosis in the Asia Pacific Region?

Harries AD, Kumar AMV, Satyanarayana S, Thekkur P, Lin Y, Dlodlo RA, Zachariah R.

Trop Med Infect Dis. 2019 Mar 15;4(1). pii: E47. doi: 10.3390/tropicalmed4010047.

30.

IPT in people living with HIV in Myanmar: a five-fold decrease in incidence of TB disease and all-cause mortality.

Kyaw NTT, Kumar AMV, Kyaw KWY, Satyanarayana S, Magee MJ, Min AC, Moe J, Aung ZZ, Aung TK, Oo MM, Soe KT, Oo HN, Aung ST, Harries AD.

Int J Tuberc Lung Dis. 2019 Mar 1;23(3):322-330. doi: 10.5588/ijtld.18.0448.

PMID:
30871663
31.

Patient characteristics, health seeking and delays among new sputum smear positive TB patients identified through active case finding when compared to passive case finding in India.

Shewade HD, Gupta V, Satyanarayana S, Pandey P, Bajpai UN, Tripathy JP, Kathirvel S, Pandurangan S, Mohanty S, Ghule VH, Sagili KD, Prasad BM, Nath S, Singh P, Singh K, Singh R, Jayaraman G, Rajeswaran P, Srivastava BK, Biswas M, Mallick G, Bera OP, Sahai KN, Murali L, Kamble S, Deshpande M, Kumar N, Kumar S, Jaisingh AJJ, Naqvi AJ, Verma P, Ansari MS, Mishra PC, Sumesh G, Barik S, Mathew V, Lohar MRS, Gaurkhede CS, Parate G, Bale SY, Koli I, Bharadwaj AK, Venkatraman G, Sathiyanarayanan K, Lal J, Sharma AK, Rao R, Kumar AMV, Chadha SS.

PLoS One. 2019 Mar 13;14(3):e0213345. doi: 10.1371/journal.pone.0213345. eCollection 2019.

32.

Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries.

Harries AD, Schwoebel V, Monedero-Recuero I, Aung TK, Chadha S, Chiang CY, Conradie F, Dongo JP, Heldal E, Jensen P, Nyengele JPK, Koura KG, Kumar AMV, Lin Y, Mlilo N, Nakanwagi-Mukwaya A, Ncube RT, Nyinoburyo R, Oo NL, Patel LN, Piubello A, Rusen ID, Sanda T, Satyanarayana S, Syed I, Thu AS, Tonsing J, Trébucq A, Zamora V, Zishiri C, Hinderaker SG, Aït-Khaled N, Roggi A, Caminero Luna J, Graham SM, Dlodlo RA, Fujiwara PI.

Int J Tuberc Lung Dis. 2019 Feb 1;23(2):241-251. doi: 10.5588/ijtld.18.0207.

PMID:
30808459
33.

Tuberculosis screening among pregnant women attending a tertiary care hospital in Puducherry, South India: is it worth the effort?

Vijayageetha M, Kumar AM, Ramakrishnan J, Sarkar S, Papa D, Mehta K, Joseph NM, Rajaram M, Rajaa S, Chinnakali P.

Glob Health Action. 2019;12(1):1564488. doi: 10.1080/16549716.2018.1564488.

34.

Tuberculosis notification in a private tertiary care teaching hospital in South India: a mixed-methods study.

Siddaiah A, Ahmed MN, Kumar AMV, D'Souza G, Wilkinson E, Maung TM, Rodrigues R.

BMJ Open. 2019 Feb 19;9(2):e023910. doi: 10.1136/bmjopen-2018-023910.

35.

Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain® Line Probe Assay in Southern provinces, Zimbabwe.

Timire C, Sandy C, Kumar AMV, Ngwenya M, Murwira B, Takarinda KC, Harries AD.

Int J Infect Dis. 2019 Apr;81:236-243. doi: 10.1016/j.ijid.2019.02.007. Epub 2019 Feb 15.

36.

How many sputum samples should be examined during follow-up of tuberculosis patients in Myanmar: two or one?

Win EE, Kumar AMV, Kyaw NTT, Aye NN, Hteik KM, Saw S, Oo MM, Kyaw KWY, Aung ST, Tun TL.

Public Health Action. 2018 Dec 21;8(4):169-174. doi: 10.5588/pha.18.0041.

37.

Hyperglycemia and Risk of All-cause Mortality Among People Living With HIV With and Without Tuberculosis Disease in Myanmar (2011-2017).

Kyaw NTT, Satyanarayana S, Oo HN, Kumar AMV, Harries AD, Aung ST, Kyaw KWY, Phyo KH, Aung TK, Magee MJ.

Open Forum Infect Dis. 2018 Dec 28;6(1):ofy355. doi: 10.1093/ofid/ofy355. eCollection 2019 Jan. Erratum in: Open Forum Infect Dis. 2019 Apr 02;6(4):ofz143.

38.

Beyond 'cure' and 'treatment success': quality of life of patients with multidrug-resistant tuberculosis.

Laxmeshwar C, Stewart AG, Dalal A, Kumar AMV, Kalaiselvi S, Das M, Gawde N, Thi SS, Isaakidis P.

Int J Tuberc Lung Dis. 2019 Jan 1;23(1):73-81. doi: 10.5588/ijtld.18.0149.

PMID:
30674378
39.

Uptake of antiretroviral therapy in HIV-positive women ever enrolled into 'prevention of mother to child transmission' programme, Mandalay, Myanmar-a cohort study.

Kyaw KWY, Satyanarayana S, Phyo KH, Kyaw NTT, Mon AA, Lwin TT, Aung TK, Oo MM, Aung ZZ, Htun T, Kham NSN, Mya T, Kumar AMV, Oo HN.

BMC Pregnancy Childbirth. 2018 Dec 4;18(1):474. doi: 10.1186/s12884-018-2099-0.

40.

Challenges and Progress with Diagnosing Pulmonary Tuberculosis in Low- and Middle-Income Countries.

Harries AD, Kumar AMV.

Diagnostics (Basel). 2018 Nov 23;8(4). pii: E78. doi: 10.3390/diagnostics8040078. Review.

41.

Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India.

Moonan PK, Nair SA, Agarwal R, Chadha VK, Dewan PK, Gupta UD, Ho CS, Holtz TH, Kumar AM, Kumar N, Kumar P, Maloney SA, Mase SR, Oeltmann JE, Paramasivan CN, Parmar MM, Rade KK, Ramachandran R, Rao R, Salhorta VS, Sarin R, Sarin S, Sachdeva KS, Selvaraju S, Singla R, Surie D, Tonsing J, Tripathy SP, Khaparde SD.

BMJ Glob Health. 2018 Oct 8;3(5):e001135. doi: 10.1136/bmjgh-2018-001135. eCollection 2018.

42.

Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and Urologists.

Kim SP, Gross CP, Shah ND, Tilburt JC, Konety B, Williams SB, Weight CJ, Yu JB, Kumar AMS, Meropol NJ.

Ann Surg Oncol. 2019 Feb;26(2):660-668. doi: 10.1245/s10434-018-6863-1. Epub 2018 Oct 11.

PMID:
30311161
43.

Publisher Correction: Evidence linking microRNA suppression of essential prosurvival genes with hippocampal cell death after traumatic brain injury.

Boone DK, Weisz HA, Bi M, Falduto MT, Torres KEO, Willey HE, Volsko CM, Kumar AM, Micci MA, Dewitt DS, Prough DS, Hellmich HL.

Sci Rep. 2018 Oct 8;8(1):14994. doi: 10.1038/s41598-018-31991-5.

44.

How can integrated care and research assist in achieving the SDG targets for diabetes, tuberculosis and HIV/AIDS?

Harries AD, Lin Y, Kumar AMV, Satyanarayana S, Zachariah R, Dlodlo RA.

Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1117-1126. doi: 10.5588/ijtld.17.0677. Review.

PMID:
30236178
45.

Active case finding among marginalised and vulnerable populations reduces catastrophic costs due to tuberculosis diagnosis.

Shewade HD, Gupta V, Satyanarayana S, Kharate A, Sahai KN, Murali L, Kamble S, Deshpande M, Kumar N, Kumar S, Pandey P, Bajpai UN, Tripathy JP, Kathirvel S, Pandurangan S, Mohanty S, Ghule VH, Sagili KD, Prasad BM, Nath S, Singh P, Singh K, Singh R, Jayaraman G, Rajeswaran P, Srivastava BK, Biswas M, Mallick G, Bera OP, Jaisingh AJJ, Naqvi AJ, Verma P, Ansari MS, Mishra PC, Sumesh G, Barik S, Mathew V, Lohar MRS, Gaurkhede CS, Parate G, Bale SY, Koli I, Bharadwaj AK, Venkatraman G, Sathiyanarayanan K, Lal J, Sharma AK, Rao R, Kumar AMV, Chadha SS; as members of the Axshya SAMVAD study group.

Glob Health Action. 2018;11(1):1494897. doi: 10.1080/16549716.2018.1494897.

46.

Delay before drug susceptibility testing among patients with presumptive multidrug-resistant tuberculosis in Gujarat, India.

Shewade HD, Shringarpure KS, Parmar M, Patel N, Kuriya S, Shihora S, Ninama N, Gosai N, Khokhariya R, Popat C, Thanki H, Modi B, Dave P, Baxi RK, Kumar AMV.

Trans R Soc Trop Med Hyg. 2018 Nov 1;112(11):500-508. doi: 10.1093/trstmh/try091.

PMID:
30137546
47.

Does the Structured Operational Research and Training Initiative (SORT IT) continue to influence health policy and/or practice?

Tripathy JP, Kumar AM, Guillerm N, Berger SD, Bissell K, Reid A, Zachariah R, Ramsay A, Harries AD.

Glob Health Action. 2018;11(1):1500762. doi: 10.1080/16549716.2018.1500762.

48.

Biocompatible hydrophilic brushite coatings on AZX310 and AM50 alloys for orthopaedic implants.

Sasikumar Y, Kumar AM, Babu RS, Rahman MM, Samyn LM, de Barros ALF.

J Mater Sci Mater Med. 2018 Jul 21;29(8):123. doi: 10.1007/s10856-018-6131-8.

PMID:
30032462
49.

What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030?

Harries AD, Lin Y, Kumar AMV, Satyanarayana S, Takarinda KC, Dlodlo RA, Zachariah R, Olliaro P.

F1000Res. 2018 Jul 5;7. pii: F1000 Faculty Rev-1011. doi: 10.12688/f1000research.14821.1. eCollection 2018. Review.

50.

How has the Zimbabwe mycobacterial culture and drug sensitivity testing system among re-treatment tuberculosis patients functioned during the scale-up of the Xpert MTB/RIF assay?

Timire C, Takarinda KC, Harries AD, Mutunzi H, Manyame-Murwira B, Kumar AMV, Sandy C.

Trans R Soc Trop Med Hyg. 2018 Jun 1;112(6):285-293. doi: 10.1093/trstmh/try054.

Supplemental Content

Loading ...
Support Center